Abstract
The blood–brain barrier (BBB) and blood–cerebrospinal fluid barrier (BCSFB) represent major control checkpoints protecting the CNS, by exerting selective control over the movement of organic cations and anions into and out of the CNS compartment. In addition, multiple CNS cell types, e.g., astrocytes, ependymal cells, microglia, contribute to processes that maintain the status quo of the CNS milieu. To fulfill their roles, these barriers and cell types express a multitude of transporter proteins from dozens of different transporter families. Fundamental advances over the past few decades in our knowledge of transporter substrates, expression profiles, and consequences of loss of function are beginning to change basic theories regarding the contribution of various cell types and clearance networks to coordinated neuronal signaling, complex organismal behaviors, and overall CNS homeostasis. In particular, transporters belonging to the Solute Carrier (SLC) superfamily are emerging as major contributors, including the SLC22 organic cation/anion/zwitterion family of transporters (includes OCT1–3 and OCTN1–3), the SLC29 facilitative nucleoside family of transporters (includes PMAT), and the SLC47 multidrug and toxin extrusion family of transporters (includes MATE1–2). These transporters are known to interact with neurotransmitters, antidepressant and anxiolytic agents, and drugs of abuse. Clarifying their contributions to the underlying mechanisms regulating CNS permeation and clearance, as well as the health status of astrocyte, microglial and neuronal cell populations, will drive new levels of understanding as to maintenance of the CNS milieu and approaches to new therapeutics and therapeutic strategies in the treatment of CNS disorders. This chapter highlights organic cation transporters belonging to the SLC superfamily known to be expressed in the CNS, providing an overview of their identification, mechanism of action, CNS expression profile, interaction with neurotransmitters and antidepressant/antipsychotic drugs, and results from behavioral studies conducted in loss of function models (knockout/knockdown).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
Throughout this chapter the convention of using all capital letters to designate human transporters and first initial capital followed by lowercase letters to designate non-human transporters is used. Species is indicated by a lowercase letter preceding the transporter name; h = human, r = rat, m = mouse, rb = rabbit.
References
Acimovic Y, Coe RC (2002) Molecular evolution of the equilibrative nucleoside transporter family: identification of novel family members in prokaryotes and eukaryotes. Mol Biol Evol 19:2199–2210
Alnouti Y, Petrick JS, Klaassen CD (2006) Tissue distribution and ontogeny of organic cation transporters in mice. Drug Metab Dispos 34:477–482. https://doi.org/10.1124/dmd.105.006932
Amphoux A, Vialou V, Drescher E et al (2006) Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain. Neuropharmacology 50:941–952. https://doi.org/10.1016/j.neuropharm.2006.01.005
André P, Saubaméa B, Cochois-Guégan V et al (2012) Transport of biogenic amine neurotransmitters at the mouse blood-retina and blood-brain barriers by uptake1 and uptake2. J Cereb Blood Flow Metab 32:1989–2001. https://doi.org/10.1038/jcbfm.2012.109
Astorga B, Ekins S, Morales M, Wright SH (2012) Molecular determinants of ligand selectivity for the human multidrug and toxin extruder proteins MATE1 and MATE2-K. J Pharmacol Exp Ther 341:743–755. https://doi.org/10.1124/jpet.112.191577
Bacq A, Balasse L, Biala G et al (2012) Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant response. Mol Psychiatry 17:926–939. https://doi.org/10.1038/mp.2011.87
Baganz NL, Horton RE, Calderon AS et al (2008) Organic cation transporter 3: keeping the brake on extracellular serotonin in serotonin-transporter-deficient mice. Proc Natl Acad Sci U S A 105:18976–18981. https://doi.org/10.1073/pnas.0800466105
Bai M, Ma Z, Sun D et al (2017) Multiple drug transporters mediate the placental transport of sulpiride. Arch Toxicol 91:3873–3884. https://doi.org/10.1007/s00204-017-2008-8
Bednarczyk D, Ekins S, Wikel JH, Wright SH (2003) Influence of molecular structure on substrate binding to the human organic cation transporter, hOCT1. Mol Pharmacol 63:489–498. https://doi.org/10.1124/mol.63.3.489
Berezowski V, Miecz D, Marszałek M et al (2004) Involvement of OCTN2 and B0,+ in the transport of carnitine through an in vitro model of the blood-brain barrier. J Neurochem 91:860–872. https://doi.org/10.1111/j.1471-4159.2004.02752.x
Boxberger KH, Hagenbuch B, Lampe JN (2014) Common drugs inhibit human organic cation transporter 1 (OCT1)-mediated neurotransmitter uptake. Drug Metab Dispos 42:990–995. https://doi.org/10.1124/dmd.113.055095
Breidert T, Spitzenberger F, Gründemann D, Schömig E (1998) Catecholamine transport by the organic cation transporter type 1 (OCT1). Br J Pharmacol 125:218–224. https://doi.org/10.1038/sj.bjp.0702065
Busch AE, Karbach U, Miska D et al (1998) Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine. Mol Pharmacol 54:342–352. https://doi.org/10.1124/mol.54.2.342
Cano MM, Calonge ML, Ilundain AA (2010) Expression of OCTN2 and OCTN3 in the apical membrane of rat renal cortex and medulla. J Cell Physiol 223:451–459. https://doi.org/10.1002/jcp.22054
Chaves C, Campanelli F, Chapy H et al (2020) An interspecies molecular and functional study of organic cation transporters at the blood-brain barrier: from rodents to humans. Pharmaceutics 12. https://doi.org/10.3390/pharmaceutics12040308
Couroussé T, Bacq A, Belzung C et al (2015) Brain organic cation transporter 2 controls response and vulnerability to stress and GSK3β signaling. Mol Psychiatry 20:889–900. https://doi.org/10.1038/mp.2014.86
Cui M, Aras R, Christian WV et al (2009) The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway. Proc Natl Acad Sci U S A 106:8043–8048. https://doi.org/10.1073/pnas.0900358106
Dahlin A, Xia L, Kong W et al (2007) Expression and immunolocalization of the plasma membrane monoamine transporter in the brain. Neuroscience 146:1193–1211. https://doi.org/10.1016/j.neuroscience.2007.01.072.EXPRESSION
Duan H, Wang J (2010) Selective transport of monoamine neurotransmitters by human plasma membrane monoamine transporter and organic cation transporter 3. J Pharmacol Exp Ther 335:743–753. https://doi.org/10.1124/jpet.110.170142
Duan H, Wang J (2013) Impaired monoamine and organic cation uptake in choroid plexus in mice with targeted disruption of the plasma membrane monoamine transporter (Slc29a4) gene. J Biol Chem 288:3535–3544. https://doi.org/10.1074/jbc.M112.436972
Engel K, Wang J (2005) Interaction of organic cations with a newly identified plasma membrane monoamine transporter. Mol Pharmacol 68:1397–1407. https://doi.org/10.1124/mol.105.016832
Engel K, Zhou M, Wang J (2004) Identification and characterization of a novel monoamine transporter in the human brain. J Biol Chem 279:50042–50049. https://doi.org/10.1074/jbc.M407913200
Farthing CA, Sweet DH (2014) Expression and function of organic cation and anion transporters (SLC22 family) in the CNS. Curr Pharm Des 20:1472–1486. https://doi.org/10.2174/13816128113199990456
Feng N, Mo B, Johnson PL et al (2005) Local inhibition of organic cation transporters increases extracellular serotonin in the medial hypothalamus. Brain Res 1063:69–76. https://doi.org/10.1016/j.brainres.2005.09.016
Feng N, Telefont M, Kelly KJ et al (2009) Local perfusion of corticosterone in the rat medial hypothalamus potentiates d-fenfluramine-induced elevations of extracellular 5-HT concentrations. Horm Behav 56:149–157. https://doi.org/10.1016/j.yhbeh.2009.03.023
Garbarino VR, Santos TA, Nelson AR et al (2019) Prenatal metformin exposure or organic cation transporter 3 knock-out curbs social interaction preference in male mice. Pharmacol Res 140:21–32. https://doi.org/10.1016/j.phrs.2018.11.013
Gasser PJ, Lowry CA, Orchinik M (2006) Corticosterone-sensitive monoamine transport in the rat dorsomedial hypothalamus: potential role for organic cation transporter 3 in stress-induced modulation of monoaminergic neurotransmission. J Neurosci 26:8758–8766. https://doi.org/10.1523/JNEUROSCI.0570-06.2006
Gasser PJ, Orchinik M, Raju I, Lowry CA (2009) Distribution of organic cation transporter 3, a corticosterone-sensitive monoamine transporter, in the rat brain. J Comp Neurol 512:529–555. https://doi.org/10.1002/cne.21921
Gasser PJ, Hurley MM, Chan J, Pickel VM (2017) Organic cation transporter 3 (OCT3) is localized to intracellular and surface membranes in select glial and neuronal cells within the basolateral amygdaloid complex of both rats and mice. Brain Struct Funct 222:1913–1928. https://doi.org/10.1007/s00429-016-1315-9.Organic
Geier EG, Chen EC, Webb A et al (2013) Profiling solute carrier transporters in the human blood-brain barrier. Clin Pharmacol Ther 94:636–639. https://doi.org/10.1038/clpt.2013.175
Gerhard A, Pavese N, Hotton G et al (2006) In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson’s disease. Neurobiol Dis 21:404–412. https://doi.org/10.1016/j.nbd.2005.08.002
Gilman TL, George CM, Vitela M et al (2018) Constitutive plasma membrane monoamine transporter (PMAT, Slc29a4) deficiency subtly affects anxiety-like and coping behaviours. Eur J Neurosci 48:1706–1716. https://doi.org/10.1111/ejn.13968
Gorboulev V, Ulzheimer JC, Akhoundova A et al (1997) Cloning and characterization of two human polyspecific organic cation transporters. DNA Cell Biol 16:871–881. https://doi.org/10.1089/dna.1997.16.871
Green R, Lo K, Sterritt C, Beier D (1999) Cloning and functional expression of a mouse liver organic cation transporter. Hepatology 29:1556–1562
Grundemann D, Gorboulev V, Gambaryan S et al (1994) Drug excretion mediated by a new prototype of polyspecific transporter. Nature 372:549–552
Gründemann D, Gorboulev V, Gambaryan S et al (1994) Drug excretion mediated by a new prototype of polyspecific transporter. Nature 372:549–552
Gründemann D, Babin-Ebell J, Martel F et al (1997) Primary structure and functional expression of the apical organic cation transporter from kidney epithelial LLC-PK1 cells. J Biol Chem 272:10408–10413. https://doi.org/10.1074/jbc.272.16.10408
Grundemann D, Schechinger B, Rappold GA, Schomig E (1998) Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter. Nat Neurosci 1:349–351. https://doi.org/10.1038/1557
Gründemann D, Schechinger B, Rappold GA, Schömig E (1998) Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter. Nat Neurosci 1:349–351. https://doi.org/10.1038/1557
Gründemann D, Liebich G, Kiefer N et al (1999) Selective substrates for non-neuronal monoamine transporters. Mol Pharmacol 56:1–10. https://doi.org/10.1124/mol.56.1.1
Haenisch B, Bönisch H (2010) Interaction of the human plasma membrane monoamine transporter (hPMAT) with antidepressants and antipsychotics. Naunyn Schmiedeberg’s Arch Pharmacol 381:33–39. https://doi.org/10.1007/s00210-009-0479-8
Haenisch B, Drescher E, Thiemer L et al (2012) Interaction of antidepressant and antipsychotic drugs with the human organic cation transporters hOCT1, hOCT2 and hOCT3. Naunyn Schmiedeberg’s Arch Pharmacol 385:1017–1023. https://doi.org/10.1007/s00210-012-0781-8
He Q, Wang Q, Yuan C, Wang Y (2017) Downregulation of miR-7116-5p in microglia by MPP+ sensitizes TNF-α production to induce dopaminergic neuron damage. Glia 65:1251–1263. https://doi.org/10.1002/glia.23153
Hill JE, Gasser PJ (2013) Organic cation transporter 3 is densely expressed in the intercalated cell groups of the amygdala: anatomical evidence for a stress hormone-sensitive dopamine clearance system. J Chem Neuroanat 52:36–43. https://doi.org/10.1016/j.jchemneu.2013.04.007
Holleran KM, Rose JH, Fordahl SC et al (2020) Organic cation transporter 3 and the dopamine transporter differentially regulate catecholamine uptake in the basolateral amygdala and nucleus accumbens. Eur J Neurosci 52:4546–4562. https://doi.org/10.1111/ejn.14927
Huang KM, Leblanc AF, Uddin ME et al (2020) Neuronal uptake transporters contribute to oxaliplatin neurotoxicity in mice. J Clin Invest 130:4601–4606. https://doi.org/10.1172/JCI136796
Inazu M, Takeda H, Matsumiya T (2003) Expression and functional characterization of the extraneuronal monoamine transporter in normal human astrocytes. J Neurochem 84:43–52. https://doi.org/10.1046/j.1471-4159.2003.01566.x
Inazu M, Takeda H, Matsumiya T (2005) Molecular and functional characterization of an Na+-independent choline transporter in rat astrocytes. J Neurochem 94:1427–1437. https://doi.org/10.1111/j.1471-4159.2005.03299.x
Inazu M, Takeda H, Maehara K et al (2006) Functional expression of the organic cation/carnitine transporter 2 in rat astrocytes. J Neurochem 97:424–434. https://doi.org/10.1111/j.1471-4159.2006.03757.x
Ishimoto T, Nakamichi N, Nishijima H et al (2018) Carnitine/organic cation transporter OCTN1 negatively regulates activation in murine cultured microglial cells. Neurochem Res 43:107–119. https://doi.org/10.1007/s11064-017-2350-5
Iyer KA, Alix K, Eltit JM et al (2019) Multi-modal antidepressant-like action of 6- and 7-chloro-2-aminodihydroquinazolines in the mouse tail suspension test. Psychopharmacology 236:2093–2104. https://doi.org/10.1007/s00213-019-05203-5
Januszewicz E, Pajak B, Gajkowska B et al (2009) Organic cation/carnitine transporter OCTN3 is present in astrocytes and is up-regulated by peroxisome proliferators-activator receptor agonist. Int J Biochem Cell Biol 41:2599–2609. https://doi.org/10.1016/j.biocel.2009.08.020
Januszewicz E, Bekisz M, Mozrzymas JW, Nałecz KA (2010) High affinity carnitine transporters from OCTN family in neural cells. Neurochem Res 35:743–748. https://doi.org/10.1007/s11064-010-0131-5
Kato Y, Kubo Y, Iwata D et al (2010) Gene knockout and metabolome analysis of carnitine/organic cation transporter OCTN1. Pharm Res 27:832–840. https://doi.org/10.1007/s11095-010-0076-z
Kekuda R, Prasad PD, Wu X et al (1998) Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta. J Biol Chem 273:15971–15979
Kido Y, Tamai I, Ohnari A et al (2001) Functional relevance of carnitine transporter OCTN2 to brain distribution of L-camitine and acetyl-L-carnitine across the blood-brain barrier. J Neurochem 79:959–969. https://doi.org/10.1046/j.1471-4159.2001.00621.x
Kitaichi K, Fukuda M, Nakayama H et al (2005) Behavioral changes following antisense oligonucleotide-induced reduction of organic cation transporter-3 in mice. Neurosci Lett 382:195–200. https://doi.org/10.1016/j.neulet.2005.03.014
Koepsell H (1998) Organic cation transporters in intestine, kidney, liver, and brain. Annu Rev Physiol 60:243–266. https://doi.org/10.1146/annurev.physiol.60.1.243
Koepsell H (2020) Organic cation transporters in health and disease. Pharmacol Rev 72:253–319. https://doi.org/10.1124/pr.118.015578
Koizumi T, Nikaidoi H, Nonomura A, Yoneda T (1988) Infantile disease with microvesicular fatty infiltration of viscera spontaneously occurring in the C3H-H-2° strain of mouse with similarities to Reye’s syndrome. Lab Anim 22:83–87. https://doi.org/10.1258/002367788780746511
Kristensen A, Andersen J, Jorgensen T et al (2011) SLC6 neurotransmitter transporters: structure, function, and regulation. Pharmacol Rev 63:585–640
Lamhonwah AM, Skaug J, Scherer SW, Tein I (2003) A third human carnitine/organic cation transporter (OCTN3) as a candidate for the 5q31 Crohn’s disease locus (IBD5). Biochem Biophys Res Commun 301:98–101. https://doi.org/10.1016/S0006-291X(02)02946-7
Lamhonwah AM, Ackerley CA, Tilups A et al (2005) OCTN3 is a mammalian peroxisomal membrane carnitine transporter. Biochem Biophys Res Commun 338:1966–1972. https://doi.org/10.1016/j.bbrc.2005.10.170
Lamhonwah AM, Hawkins CE, Tam C et al (2008) Expression patterns of the organic cation/carnitine transporter family in adult murine brain. Brain and Development 30:31–42. https://doi.org/10.1016/j.braindev.2007.05.005
Li RWS, Yang C, Kwan YW et al (2013) Involvement of organic cation transporter-3 and plasma membrane monoamine transporter in serotonin uptake in human brain vascular smooth muscle cells. Front Pharmacol 4(FEB):1–8. https://doi.org/10.3389/fphar.2013.00014
Li L, Weng Y, Wang W et al (2017) Multiple organic cation transporters contribute to the renal transport of sulpiride. Biopharm Drug Dispos 38:526–534. https://doi.org/10.1002/bdd.2104
Lin C-J, Tai Y, Huang M-T et al (2010) Cellular localization of the organic cation transporters, OCT1 and OCT2, in brain microvessel endothelial cells and its implication for MPTP transport across the blood-brain barrier and MPTP-induced dopaminergic toxicity in rodents. J Neurochem 114:717–727. https://doi.org/10.1111/j.1471-4159.2010.06801.x
Lips KS, Volk C, Schmitt BM et al (2005) Polyspecific cation transporters mediate luminal release of acetylcholine from bronchial epithelium. Am J Respir Cell Mol Biol 33:79–88. https://doi.org/10.1165/rcmb.2004-0363OC
Lu KM, Nishimori H, Nakamura Y et al (1998) A missense mutation of mouse OCTN2, a sodium-dependent carnitine cotransporter, in the juvenile visceral steatosis mouse. Biochem Biophys Res Commun 252:590–594. https://doi.org/10.1006/bbrc.1998.9708
Marcinkiewcz CA, Devine DP (2015) Modulation of OCT3 expression by stress, and antidepressant-like activity of decynium-22 in an animal model of depression. Pharmacol Biochem Behav 131:33–41. https://doi.org/10.1016/j.pbb.2015.01.004
Massmann V, Edemir B, Schlatter E et al (2014) The organic cation transporter 3 (OCT3) as molecular target of psychotropic drugs: transport characteristics and acute regulation of cloned murine OCT3. Pflugers Arch Eur J Physiol 466:517–527. https://doi.org/10.1007/s00424-013-1335-8
Masuda S, Terada T, Yonezawa A et al (2006) Identification and functional characterization of a new human kidney-specific H+/organic cation antiporter, kidney-specific multidrug and toxin extrusion 2. J Am Soc Nephrol 17:2127–2135. https://doi.org/10.1681/ASN.2006030205
Mayer FP, Schmid D, Owens WA et al (2018) An unsuspected role for organic cation transporter 3 in the actions of amphetamine. Neuropsychopharmacology 43:2408–2417. https://doi.org/10.1038/s41386-018-0053-5
Miecz D, Januszewicz E, Czeredys M et al (2008) Localization of organic cation/carnitine transporter (OCTN2) in cells forming the blood-brain barrier. J Neurochem 104:113–123. https://doi.org/10.1111/j.1471-4159.2007.05024.x
Miura Y, Yoshikawa T, Naganuma F et al (2017) Characterization of murine polyspecific monoamine transporters. FEBS Open Bio 7:237–248. https://doi.org/10.1002/2211-5463.12183
Monte J, Nagle M, Eraly S, Nigam S (2004) Identification of a novel murine organic anion transporter family member, OAT6, expressed in olfactory mucosa. Biochem Biophys Res Commun 323:429–436
Mooslehner KA, Allen ND (1999) Cloning of the mouse organic cation transporter 2 gene, Slc22a2, from an enhancer-trap transgene integration locus. Mamm Genome 10:218–224. https://doi.org/10.1007/s003359900976
Nakamichi N, Taguchi T, Hosotani H et al (2012) Functional expression of carnitine/organic cation transporter OCTN1 in mouse brain neurons: possible involvement in neuronal differentiation. Neurochem Int 61:1121–1132. https://doi.org/10.1016/j.neuint.2012.08.004
Nakayama H, Kitaichi K, Ito Y et al (2007) The role of organic cation transporter-3 in methamphetamine disposition and its behavioral response in rats. Brain Res 1184:260–269. https://doi.org/10.1016/j.brainres.2007.09.072
Nies AT, Herrmann E, Brom M, Keppler D (2008) Vectorial transport of the plant alkaloid berberine by double-transfected cells expressing the human organic cation transporter 1 (OCT1, SLC22A1) and the efflux pump MDR1 P-glycoprotein (ABCB1). Naunyn Schmiedeberg's Arch Pharmacol 376:449–461. https://doi.org/10.1007/s00210-007-0219-x
Okura T, Hattori A, Takano Y et al (2008) Involvement of the pyrilamine transporter, a putative organic cation transporter, in blood-brain barrier transport of oxycodone. Drug Metab Dispos 36:2005–2013. https://doi.org/10.1124/dmd.108.022087
Okura T, Kato S, Takano Y et al (2011) Functional characterization of rat plasma membrane monoamine transporter in the blood-brain and blood-cerebrospinal fluid barriers. J Pharm Sci 100:3924–3938. https://doi.org/10.1002/jps.22594
Otsuka M, Matsumoto T, Morimoto R et al (2005) A human transporter protein that mediates the final excretion step for toxic organic cations. Proc Natl Acad Sci U S A 102:17923–17928. https://doi.org/10.1073/pnas.0506483102
Pan X, Iyer KA, Sweet DH et al (2017) A new chemotype inhibitor for the human organic cation transporter 3 (hOCT3). Bioorg Med Chem Lett 27:4440–4445. https://doi.org/10.1016/j.bmcl.2017.08.008
Pereira JNDS, Tadjerpisheh S, Abed MA et al (2014) The poorly membrane permeable antipsychotic drugs amisulpride and sulpiride are substrates of the organic cation transporters from the slc22 family. AAPS J 16:1247–1256. https://doi.org/10.1208/s12248-014-9649-9
Pochini L, Scalise M, Galluccio M et al (2012) The human OCTN1 (SLC22A4) reconstituted in liposomes catalyzes acetylcholine transport which is defective in the mutant L503F associated to the Crohn’s disease. Biochim Biophys Acta Biomembr 1818:559–565. https://doi.org/10.1016/j.bbamem.2011.12.014
Russ H, Staudt K, Martel F et al (1996) The extraneuronal transporter for monoamine transmitters exists in cells derived from human central nervous system glia. Eur J Neurosci 8:1256–1264
Sandoval PJ, Zorn KM, Clark AM et al (2018) Assessment of substrate-dependent ligand interactions at the organic cation transporter OCT2 using six model substrates s. Mol Pharmacol 94:1057–1068. https://doi.org/10.1124/mol.117.111443
Schmitt A, Mossner R, Gossmann A et al (2003) Organic cation transporter capable of transporting serotonin is up-regulated in serotonin transporter-deficient mice. J Neurosci Res 71:701–709. https://doi.org/10.1002/jnr.10521
Shi R, Yang Y, Xu Z et al (2018) Renal vectorial transport of berberine mediated by organic cation transporter 2 (OCT2) and multidrug and toxin extrusion proteins 1 (MATE1) in rats. Biopharm Drug Dispos 39:47–58. https://doi.org/10.1002/bdd.2112
Shi R, Xu Z, Xu X et al (2019) Organic cation transporter and multidrug and toxin extrusion 1 co-mediated interaction between metformin and berberine. Eur J Pharm Sci 127:282–290. https://doi.org/10.1016/j.ejps.2018.11.010
Shirasaka Y, Lee N, Duan H et al (2017) Interspecies comparison of the functional characteristics of plasma membrane monoamine transporter (PMAT) between human, rat and mouse. J Chem Neuroanat 83–84:99–106. https://doi.org/10.1016/j.jchemneu.2016.09.006
Simard AR, Soulet D, Gowing G et al (2006) Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer’s disease. Neuron 49:489–502. https://doi.org/10.1016/j.neuron.2006.01.022
Slitt AL, Cherrington NJ, Hartley DP et al (2002) Tissue distribution and renal developmental changes in rat organic cation transporter mRNA levels. Drug Metab Dispos 30:212–219. https://doi.org/10.1124/dmd.30.2.212
Song W, Luo Q, Zhang Y et al (2019) Organic cation transporter 3 (Oct3) is a distinct catecholamines clearance route in adipocytes mediating the beiging of white adipose tissue. PLoS Biol 17:1–28. https://doi.org/10.1371/journal.pbio.2006571
Sprowl JA, Ciarimboli G, Lancaster CS et al (2013) Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2. Proc Natl Acad Sci U S A 110:11199–11204. https://doi.org/10.1073/pnas.1305321110
Suhre WM, Ekins S, Chang C et al (2005) Molecular determinants of substrate/inhibitor binding to the human and rabbit renal organic cation transporters hOCT2 and rbOCT2. Mol Pharmacol 67:1067–1077. https://doi.org/10.1124/mol.104.004713
Sun S, Wang K, Lei H et al (2014) Inhibition of organic cation transporter 2 and 3 may be involved in the mechanism of the antidepressant-like action of berberine. Prog Neuro-Psychopharmacol Biol Psychiatry 49:1–6. https://doi.org/10.1016/j.pnpbp.2013.11.005
Sweet DH, Pritchard JB (1999) rOCT2 is a basolateral potential-driven carrier, not an organic cation/proton exchanger. Am J Physiol Ren Physiol 277:F890–F898. https://doi.org/10.1152/ajprenal.1999.277.6.f890
Sweet DH, Miller DS, Pritchard JB (2001) Ventricular choline transport: a role for organic cation transporter 2 expressed in choroid plexus. J Biol Chem 276:41611–41619. https://doi.org/10.1074/jbc.M108472200
Takano H, Ito S, Zhang X et al (2017) Possible role of organic cation transporters in the distribution of [11C] sulpiride, a dopamine D2 receptor antagonist. J Pharm Sci 106:2558–2565. https://doi.org/10.1016/j.xphs.2017.05.006
Tamai I, Yabuuchi H, Nezu JI et al (1997) Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1. FEBS Lett 419:107–111. https://doi.org/10.1016/S0014-5793(97)01441-5
Tamai I, Ohashi R, Nezu JI et al (1998) Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J Biol Chem 273:20378–20382. https://doi.org/10.1074/jbc.273.32.20378
Tamai I, Ohashi R, Nezu JI et al (2000) Molecular and functional characterization of organic cation/carnitine transporter family in mice. J Biol Chem 275:40064–40072. https://doi.org/10.1074/jbc.M005340200
Tamai I, Nakanishi T, Kobayashi D et al (2004) Involvement of OCTN1 (SLC22A4) in pH-dependent transport of organic cations. Mol Pharm 1:57–66. https://doi.org/10.1021/mp0340082
Terada T, Masuda S, Asaka JI et al (2006) Molecular cloning, functional characterization and tissue distribution of rat H+/organic cation antiporter MATE1. Pharm Res 23:1696–1701. https://doi.org/10.1007/s11095-006-9016-3
Terashita S, Dresser MJ, Zhang L et al (1998) Molecular cloning and functional expression of a rabbit renal organic cation transporter. Biochim Biophys Acta Biomembr 1369:1–6. https://doi.org/10.1016/S0005-2736(97)00207-1
Tsuda M, Terada T, Asaka JI et al (2007) Oppositely directed H+ gradient functions as a driving force of rat H+/organic cation antiporter MATE1. Am J Physiol Ren Physiol 292:593–598. https://doi.org/10.1152/ajprenal.00312.2006
Tzvetkov MV, dos Santos Pereira JN, Meineke I et al (2013) Morphine is a substrate of the organic cation transporter OCT1 and polymorphisms in OCT1 gene affect morphine pharmacokinetics after codeine administration. Biochem Pharmacol 86:666–678. https://doi.org/10.1016/j.bcp.2013.06.019
Uchida Y, Zhang Z, Tachikawa M, Terasaki T (2015) Quantitative targeted absolute proteomics of rat blood-cerebrospinal fluid barrier transporters: comparison with a human specimen. J Neurochem 134:1104–1115. https://doi.org/10.1111/jnc.13147
Verhaagh S, Schweifer N, Barlow DP, Zwart R (1999) Cloning of the mouse and human solute carrier 22a3 (Slc22a3/SLC22A3) identifies a conserved cluster of three organic cation transporters on mouse chromosome 17 and human 6q26–q27. Genomics 55:209–218
Vialou V, Amphoux A, Zwart R et al (2004) Organic cation transporter 3 (Slc22a3) is implicated in salt-intake regulation. J Neurosci 24:2846–2851. https://doi.org/10.1523/JNEUROSCI.5147-03.2004
Vialou V, Balasse L, Dumas S et al (2007) Neurochemical characterization of pathways expressing plasma membrane monoamine transporter in the rat brain. Neuroscience 144:616–622. https://doi.org/10.1016/j.neuroscience.2006.09.058
Vialou V, Balasse L, Callebert J et al (2008) Altered aminergic neurotransmission in the brain of organic cation transporter 3-deficient mice. J Neurochem 106:1471–1482. https://doi.org/10.1111/j.1471-4159.2008.05506.x
Wang J (2016) The plasma membrane monoamine transporter (PMAT): structure, function, and role in organic cation disposition. Clin Pharmacol Ther 100:489–499. https://doi.org/10.1002/cpt.442
Wright SH, Dantzler WH (2004) Molecular and cellular physiology of renal organic cation and anion transport. Am J Physiol Physiol 84:987–1049. https://doi.org/10.1152/physrev.00040.2003.-Organic
Wu X, Kekuda R, Huang W et al (1998a) Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain. J Biol Chem 273:32776–32786. https://doi.org/10.1074/jbc.273.49.32776
Wu X, Prasad PD, Leibach FH, Ganapathy V (1998b) cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family. Biochem Biophys Res Commun 246:589–595. https://doi.org/10.1006/bbrc.1998.8669
Wu X, Huang W, Prasad PD et al (1999) Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter. J Pharmacol Exp Ther 290:1482–1492
Wu X, George RL, Huang W et al (2000) Structural and functional characteristics and tissue distribution pattern of rat OCTN1, an organic cation transporter, cloned from placenta. Biochim Biophys Acta Biomembr 1466:315–327. https://doi.org/10.1016/S0005-2736(00)00189-9
Wu KC, Lu YH, Peng YH et al (2015a) Decreased expression of organic cation transporters, Oct1 and Oct2, in brain microvessels and its implication to MPTP-induced dopaminergic toxicity in aged mice. J Cereb Blood Flow Metab 35:37–47. https://doi.org/10.1038/jcbfm.2014.162
Wu KC, Lu YH, Peng YH et al (2015b) Effects of lipopolysaccharide on the expression of plasma membrane monoamine transporter (PMAT) at the blood-brain barrier and its implications to the transport of neurotoxins. J Neurochem 135:1178–1188. https://doi.org/10.1111/jnc.13363
Wultsch T, Grimberg G, Schmitt A et al (2009) Decreased anxiety in mice lacking the organic cation transporter 3. J Neural Trans 116:689–697. https://doi.org/10.1007/s00702-009-0205-1
Xiao L, Xue Y, Zhang C et al (2018) The involvement of multidrug and toxin extrusion protein 1 in the distribution and excretion of berberine. Xenobiotica 48:314–323
Yabuuchi H, Tamai I, Nezu JI et al (1999) Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations. J Pharmacol Exp Ther 289:768–773
Yamamura H, Snyder S (1973) High affinity transport of choline into synaptosomes of rat brain. J Neurochem 21:1355–1374
Yoshikawa T, Naganuma F, Iida T et al (2013) Molecular mechanism of histamine clearance by primary human astrocytes. Glia 61:905–916. https://doi.org/10.1002/glia.22484
Zhang L, Dresser MJ, Gray AT et al (1997) Cloning and functional expression of a human liver organic cation transporter. Mol Pharmacol 51:913–921
Zhang L, Schaner ME, Giacomini KM (1998) Functional characterization of an organic cation transporter (hOCT1) in a transiently transfected human cell line (HeLa). J Pharmacol Exp Ther 286:354–361
Zhang X, Evans KK, Wright SH (2002) Molecular cloning of rabbit organic cation transporter rbOCT2 and functional comparisons with rbOCT1. Am J Physiol Ren Physiol 283:124–133. https://doi.org/10.1152/ajprenal.00367.2001
Zhang X, Cherrington NJ, Wright SH (2007) Molecular identification and functional characterization of rabbit MATE1 and MATE2-K. Am J Physiol Ren Physiol 293:360–370. https://doi.org/10.1152/ajprenal.00102.2007
Zhou M, Engel K, Wang J (2007) Evidence for significant contribution of a newly identified monoamine transporter (PMAT) to serotonin uptake in the human brain. Biochem Pharmacol 73:147–154. https://doi.org/10.1016/j.bcp.2006.09.008
Zhu H-J, Appel DI, Gründemann D, Markowitz JS (2010) Interaction of organic cation transporter 3 (SLC22A3) and amphetamine. J Neurochem 114:142–149. https://doi.org/10.1111/j.1471-4159.2010.06738.x
Zhu H-J, Appel DI, Gründemann D et al (2012a) Evaluation of organic cation transporter 3 (SLC22A3) inhibition as a potential mechanism of antidepressant action. Pharmacol Res 65:491–496. https://doi.org/10.1016/j.phrs.2012.01.008
Zhu P, Hata R, Ogasawara M et al (2012b) Targeted disruption of organic cation transporter 3 (Oct3) ameliorates ischemic brain damage through modulating histamine and regulatory T cells. J Cereb Blood Flow Metab 32:1897–1908. https://doi.org/10.1038/jcbfm.2012.92
Zhu P, Ye Z, Guo D et al (2018) Irinotecan alters the disposition of morphine via inhibition of organic cation transporter 1 (OCT1) and 2 (OCT2). Pharm Res 35:243. https://doi.org/10.1007/s11095-018-2526-y
Zolk O, Solbach TF, König J, Fromm MF (2009) Functional characterization of the human organic cation transporter 2 variant p.270Ala>Ser. Drug Metab Dispos 37:1312–1318. https://doi.org/10.1124/dmd.108.023762
Zwart R, Verhaagh S, Buitelaar M et al (2001) Impaired activity of the extraneuronal monoamine transporter system known as uptake-2 in Orct3/Slc22a3-deficient mice. Mol Cell Biol 21:4188–4196. https://doi.org/10.1128/mcb.21.13.4188-4196.2001
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Sweet, D.H. (2021). Organic Cation Transporter Expression and Function in the CNS. In: Daws, L.C. (eds) Organic Cation Transporters in the Central Nervous System. Handbook of Experimental Pharmacology, vol 266. Springer, Cham. https://doi.org/10.1007/164_2021_463
Download citation
DOI: https://doi.org/10.1007/164_2021_463
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-82983-4
Online ISBN: 978-3-030-82984-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)